Join us for an exclusive webinar where senior APAC M&A leaders discussed the emerging trends reshaping the dealmaking landscape.

At the final Capital for Cures spring summit in Frankfurt, biotech founders and investors explored how to close expectation gaps, build trust and secure sustainable funding in a volatile market.

Step inside the deal room with M&A advisors who specialize in middle-market transactions.

Insights from the Capital for Cures Summit in London.

Join Jesse Itzler, co-owner of the NBA Atlanta Hawks for a high-impact session on goal setting and performance. 

How dealmakers at every level can learn to lead — and succeed — with AI.

AI is redefining how fund managers approach DDQs — turning a resource drain into a competitive advantage. 

From deal sourcing to diligence, AI is streamlining corp dev.

Crescera Capital modernized its USD 500 million fundraise with SS&C Intralinks FundCentre™, creating a faster, more transparent and data-driven investor experience.